These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30408719)

  • 1. Functional signature of conversion of patients with mild cognitive impairment.
    Delli Pizzi S; Punzi M; Sensi SL;
    Neurobiol Aging; 2019 Feb; 74():21-37. PubMed ID: 30408719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging of hippocampal atrophy in early recognition of Alzheimer's disease--a critical appraisal after two decades of research.
    Schröder J; Pantel J
    Psychiatry Res Neuroimaging; 2016 Jan; 247():71-8. PubMed ID: 26774855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
    Pennanen C; Kivipelto M; Tuomainen S; Hartikainen P; Hänninen T; Laakso MP; Hallikainen M; Vanhanen M; Nissinen A; Helkala EL; Vainio P; Vanninen R; Partanen K; Soininen H
    Neurobiol Aging; 2004 Mar; 25(3):303-10. PubMed ID: 15123335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
    Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
    Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.
    deToledo-Morrell L; Stoub TR; Bulgakova M; Wilson RS; Bennett DA; Leurgans S; Wuu J; Turner DA
    Neurobiol Aging; 2004 Oct; 25(9):1197-203. PubMed ID: 15312965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment.
    Jauhiainen AM; Pihlajamäki M; Tervo S; Niskanen E; Tanila H; Hänninen T; Vanninen RL; Soininen H
    Hippocampus; 2009 Feb; 19(2):166-75. PubMed ID: 18777563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.
    Devanand DP; Bansal R; Liu J; Hao X; Pradhaban G; Peterson BS
    Neuroimage; 2012 Apr; 60(3):1622-9. PubMed ID: 22289801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.
    Stoub TR; Rogalski EJ; Leurgans S; Bennett DA; deToledo-Morrell L
    Neurobiol Aging; 2010 Jul; 31(7):1089-98. PubMed ID: 18809228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.
    Chetelat G; Baron JC
    Neuroimage; 2003 Feb; 18(2):525-41. PubMed ID: 12595205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    Marra C; Piccininni C; Masone Iacobucci G; Caprara A; Gainotti G; Costantini EM; Callea A; Venneri A; Quaranta D
    J Alzheimers Dis; 2021; 81(2):619-627. PubMed ID: 33814440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
    Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
    Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.